0001104659-23-053011.txt : 20230428 0001104659-23-053011.hdr.sgml : 20230428 20230428162219 ACCESSION NUMBER: 0001104659-23-053011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230428 FILED AS OF DATE: 20230428 DATE AS OF CHANGE: 20230428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Edwards Martin CENTRAL INDEX KEY: 0001640073 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38067 FILM NUMBER: 23866714 MAIL ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verona Pharma plc CENTRAL INDEX KEY: 0001657312 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE BUSINESS PHONE: 011-44-0-2032834200 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE 4 1 tm2314094-6_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-04-28 0 0001657312 Verona Pharma plc VRNA 0001640073 Edwards Martin 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE UNITED KINGDOM 1 0 0 0 0 Share Options (Right to Buy) 2.67 2023-04-28 4 A 0 96000 0 A 2033-04-27 Ordinary Shares 96000 96000 D The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer. The option vests and becomes exercisable as to 25% on each of July 28, 2023, October 28, 2023, January 28, 2024 and April 28, 2024. /s/ Claire Poll, Attorney-in-fact for Martin Edwards 2023-04-28